Purchase this article with an account.
J.J. Chieh, M. Liu, A. Martidis, D.B. Roth, J. Belmont, M. Nelson, C. Regillo, A. Sivalingam, J. Federman; Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3220.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To evaluate the efficacy of intravitreal triaminolone acetonide (IVT) for the treatment of diabetic macular edema. Methods: Retrospective analysis of the records of 218 patients from 2 institutions with diabetic macular edema who were treated with IVT. Results: Two Hundred and thirty-two eyes of 218 patients with diabetic macular edema were treated with IVT . Mean follow-up was 6.1 months. One hundred and seventy eight eyes (76.7%) had nonproliferative diabetic retinopathy (NPDR) and 54 eyes (23.3%) had proliferative diabetic retinopathy (PDR). One hundred and ninety five eyes (84.1%) were treated with prior focal laser photocoagulation at least once. The mean visual acuity pre-operatively was 20/160. The mean visual acuities were 20/120, 20/120, and 20/140 at 1, 3, and 6 months, respectively. One hundred and forty-one eyes had clinical resolution of macular edema (61%). Forty eyes (17.3%) were treated more than once. Visual outcomes were limited by subsequent development of vitreous hemorrhage and macular ischemia in some patients. Conclusions: IVT was successful in reducing clinical macular edema in eyes with diabetic retinopathy, but visual acuity may not always improve in eyes with diabetic macular edema.
This PDF is available to Subscribers Only